Form 4: BDX Executive Gains 2,916 Shares in Equity Awards

Sentiment:

Insider Transaction Report


Becton Dickinson & Co. executive Pavan Kumar Mocherla received 2,916 shares of common stock through restricted stock units and performance-based awards.

Summary

  • Pavan Kumar Mocherla, EVP & President, Greater Asia for Becton Dickinson & Co. (BDX), acquired 2,916 shares of common stock.
  • The acquisitions occurred on November 26, 2025, and were reported on December 1, 2025.
  • 2,208 shares were awarded as restricted stock units (RSUs) under the company's 2004 Employee and Director Equity-Based Compensation Plan.
  • An additional 708 shares were received upon the vesting of performance-based equity awards.
  • Following these transactions, Mocherla's direct beneficial ownership of BDX common stock increased to 5,763 shares.
  • The transactions were made pursuant to a Rule 10b5-1(c) pre-arranged plan.

Sentiment

Score: 7

Explanation: The sentiment is positive as an executive is increasing their beneficial ownership through equity awards, aligning their interests with shareholders. This is a routine compensation event and not indicative of operational performance, but generally viewed favorably for executive retention and motivation.

Positives

  • The executive's increased ownership aligns management incentives with shareholder interests.
  • The awards are part of a structured equity compensation plan, indicating ongoing executive retention and motivation.

Future Outlook

NA

Industry Context

This filing reflects routine executive compensation practices common across the healthcare and medical technology industries, where equity awards are a standard component of long-term incentive plans designed to align executive performance with company growth and shareholder value.

Comparison to Industry Standards

  • Equity-based compensation, including restricted stock units and performance-based awards, is a standard practice for executive remuneration in large-cap medical technology companies like Becton Dickinson & Co. This aligns with compensation structures seen at peers such as Medtronic (MDT) and Abbott Laboratories (ABT).
  • The use of a Rule 10b5-1 plan for these transactions is also a common corporate governance practice, providing an affirmative defense against insider trading allegations by pre-scheduling trades.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan UtilizationRestricted stock units were awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.11/26/2025Reinforces the company's established executive compensation framework and its commitment to long-term incentive alignment.
Trading Plan DisclosureThe transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.11/26/2025Enhances transparency and provides an affirmative defense against insider trading, reflecting sound corporate governance practices.

Related Party Transactions

  • Pavan Kumar Mocherla, an executive officer (EVP & President, Greater Asia) of Becton Dickinson & Co., received 2,208 shares as restricted stock units and 708 shares from the vesting of performance-based equity awards from the company.

Stakeholder Impact

  • Shareholders: Increased executive ownership can signal confidence and align management's long-term interests with shareholder value creation.
  • Employees: Reflects the company's ongoing use of equity compensation as part of its incentive programs, potentially impacting morale and retention for other eligible employees.

Key Dates

DateDescription
11/26/2025Date of common stock acquisition through restricted stock units and performance-based equity awards.
12/01/2025Date the Statement of Changes in Beneficial Ownership (Form 4) was signed.

Keywords

Becton Dickinson, BDX, Form 4, Insider Transaction, Equity Award, Restricted Stock Units, Performance Shares, Executive Compensation, Pavan Kumar Mocherla

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.